GREG C. SMITH - 19 May 2022 Form 4 Insider Report for LEAR CORP (LEA)

Role
Director
Signature
/s/ Karen Crittenden, as Attorney-in-Fact
Issuer symbol
LEA
Transactions as of
19 May 2022
Net transactions value
$0
Form type
4
Filing time
23 May 2022, 18:16:00 UTC
Previous filing
03 Mar 2022
Next filing
25 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEA Common Stock Options Exercise $0 +1,531 $0.000000 1,531 19 May 2022 Direct F1
holding LEA Common Stock 13,891 19 May 2022 By Children F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEA Restricted Stock Units Options Exercise $0 -1,531 -100% $0.000000* 0 19 May 2022 Common Stock 1,531 Direct F1, F3
transaction LEA Restricted Stock Units Award $0 +2,221 $0.000000 2,221 19 May 2022 Common Stock 2,221 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vested and settled in common stock on May 19, 2022.
F2 Shares held by the Ann Cournoyer Smith Irrev Trust (the "Trust") for the benefit of Reporting Person's children. Reporting Person is the trustee of the Trust. The reporting person disclaims beneficial ownership of the shares held by the Trust and this report should not be deemed an admission that the reporting person is the beneficial owner of the Trust's shares for purposes of Section 16 or any other purpose.
F3 Each restricted stock unit is convertible into a share of common stock on a 1-for-1 basis.
F4 The restricted stock units were granted on May 19, 2022, under the Lear Corporation 2019 Long Term Stock Incentive Plan. The restricted stock units vest and settle in common stock on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of the stockholders following the date of grant.